Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

[Updated treatment of peritoneal carcinomas: a review].

Deraco M, Laterza B, Kusamura S, Baratti D.

Minerva Chir. 2007 Dec;62(6):459-76. Review. Italian.

PMID:
18091656
2.

[Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].

Vaira M, Scuderi S, Costamagna D, Barone R, Aghemo B, Mioli PR, De Simone M.

Minerva Chir. 2002 Oct;57(5):597-605. Review. Italian.

PMID:
12370661
3.

Peritoneal-based malignancies and their treatment.

Teo M.

Ann Acad Med Singapore. 2010 Jan;39(1):54-7. Review.

4.

[Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].

Kavanagh M, Ouellet JF; Comité de l'Evolution des Pratiques en Oncologie..

Bull Cancer. 2006 Sep;93(9):867-74. Review. French.

5.

[Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].

Eveno C, Dagois S, Guillot E, Gornet JM, Pocard M.

Bull Cancer. 2008 Jan;95(1):141-5. doi: 10.1684/bdc.2008.0553. Review. French.

6.

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.

Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL.

J Cancer Res Clin Oncol. 2009 Dec;135(12):1637-45. doi: 10.1007/s00432-009-0667-4. Epub 2009 Aug 23. Review.

PMID:
19701772
7.

Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy.

Winder T, Lenz HJ.

Oncologist. 2010;15(8):836-44. doi: 10.1634/theoncologist.2010-0052. Epub 2010 Jul 23. Review.

8.

Peritoneal metastases: challenges for the surgeon.

Baratti D, Kusamura S, Guaglio M, Deraco M.

Minerva Chir. 2015 Jun;70(3):195-215. Epub 2015 Mar 10. Review.

PMID:
25752673
9.
10.

Clinical results of cytoreduction and HIPEC in pseudomyxoma peritonei.

Lutton NJ, Moran BJ.

Cancer Treat Res. 2007;134:319-28. Review. No abstract available.

PMID:
17633063
11.

Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve.

Mohamed F, Moran BJ.

Cancer J. 2009 May-Jun;15(3):196-9. doi: 10.1097/PPO.0b013e3181a58d56. Review.

PMID:
19556904
12.

Peritoneal mesothelioma.

Mohamed F, Sugarbaker PH.

Curr Treat Options Oncol. 2002 Oct;3(5):375-86. Review.

PMID:
12194803
13.

Surgical treatment of peritoneal carcinomatosis: current treatment modalities.

Kulu Y, Müller-Stich B, Büchler MW, Ulrich A.

Langenbecks Arch Surg. 2014 Jan;399(1):41-53. doi: 10.1007/s00423-013-1144-8. Epub 2013 Nov 19. Review.

PMID:
24249036
14.

Malignant peritoneal mesothelioma.

Loggie BW.

Curr Treat Options Oncol. 2001 Oct;2(5):395-9. Review.

PMID:
12057102
15.
16.

Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma.

Alexander HR, Hanna N, Pingpank JF.

Cancer Treat Res. 2007;134:343-55. Review.

PMID:
17633065
17.

[Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy].

Scuderi S, Costamagna D, Vaira M, Barone R, De Simone M.

Tumori. 2003 Jul-Aug;89(4 Suppl):43-5. Review. Italian.

PMID:
12903542
18.

Management of peritoneal surface malignancy: a review of the recent literature.

Halkia E, Gavriel S, Spiliotis J.

J BUON. 2014 Jul-Sep;19(3):618-26. Review.

PMID:
25261643
19.

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.

Glockzin G, Ghali N, Lang SA, Schlitt HJ, Piso P.

J Surg Oncol. 2009 Sep 15;100(4):306-10. doi: 10.1002/jso.21332. Review.

PMID:
19697436

Supplemental Content

Support Center